ArticleClinical and translational science2024
Correction to "Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.